What Are Peptides? A Plain Language Guide
Peptide Fundamentals
80+ FDA-approved
More than 80 peptide drugs have been approved by the FDA, with over 150 in active clinical development. The peptide therapeutics market exceeds $50 billion annually.
Rosson et al., European Journal of Pharmaceutics, 2025
Rosson et al., European Journal of Pharmaceutics, 2025
View as imageYour body runs on peptides. Every time your blood sugar drops, a peptide (insulin) tells your cells to absorb glucose. Every time you eat a meal, peptides (GLP-1, PYY, CCK) tell your brain you are full. Every time bacteria breach your skin, peptides (defensins, cathelicidins) kill the invaders on contact. Peptides are short chains of amino acids, typically between 2 and 50 units long, that serve as the body's chemical messengers, immune defenders, and biological regulators. They are smaller than proteins but far more than simple building blocks. Understanding what peptides are and how they work is the foundation for understanding the fastest-growing category of pharmaceutical drugs. For a deeper look at the chemistry behind how amino acids connect, see our pillar article on the peptide bond.
Key Takeaways
- Peptides are chains of 2-50 amino acids linked by peptide bonds; proteins are longer chains (50+ amino acids) that fold into complex three-dimensional structures[1]
- Your body produces over 7,000 known naturally occurring peptides that regulate hormones, immunity, digestion, pain, mood, and blood pressure[2]
- More than 80 peptide drugs have FDA approval, with the peptide therapeutics market exceeding $50 billion globally[1]
- Peptide hormones (insulin, growth hormone, oxytocin) work by binding to receptors on cell surfaces, triggering intracellular signaling cascades[3]
- Antimicrobial peptides are part of your innate immune system, killing bacteria by disrupting their cell membranes within minutes[4]
- The main limitation of peptide drugs is their fragility: most are destroyed by stomach acid and digestive enzymes, requiring injection rather than oral pills[5]
Amino Acids, Peptides, and Proteins: The Size Spectrum
Everything starts with amino acids. These are small organic molecules, each containing an amino group (NH2), a carboxyl group (COOH), and a unique side chain that gives each amino acid its properties. Your body uses 20 standard amino acids to build every peptide and protein it needs.
When two amino acids link together through a chemical reaction called a condensation reaction, they form a peptide bond, a strong covalent bond between the amino group of one and the carboxyl group of the other. Chain two amino acids together and you have a dipeptide. Chain three and you have a tripeptide. Keep going and you build longer chains: oligopeptides (2-20 amino acids), polypeptides (20-50), and eventually proteins (50+).
The boundary between peptide and protein is not rigid. Insulin, with 51 amino acids, is often called both a peptide hormone and a small protein. Where exactly the line falls depends on context: biochemists typically use 50 amino acids as the cutoff, while pharmacologists may classify anything under 100 amino acids as a peptide. What matters more than the label is the behavior: peptides are generally too short to fold into the stable three-dimensional structures that define protein function. Their shape and structure are simpler, which makes them faster to synthesize but also more vulnerable to degradation.
What Peptides Do in Your Body
Peptides perform an extraordinary range of biological functions. Grouping them by role makes the landscape easier to navigate.
Peptide Hormones
These are the signaling molecules that coordinate activity across distant organs. When your pancreatic beta cells release insulin (51 amino acids), it travels through your bloodstream to muscle, fat, and liver cells, telling them to take up glucose. When your hypothalamus releases gonadotropin-releasing hormone (GnRH, 10 amino acids), it triggers a cascade that ultimately controls testosterone and estrogen production.
Sanders et al. (2008) demonstrated that peptide hormones also serve as developmental growth factors, acting locally in developing tissues rather than only as long-distance endocrine signals.[3] This dual role, acting both locally and systemically, is characteristic of peptide biology.
Other examples: growth hormone-releasing hormone (GHRH), oxytocin (9 amino acids, controls labor and social bonding), vasopressin (9 amino acids, controls water retention), and the incretin hormones GLP-1 and GIP that are now the basis of blockbuster weight loss drugs. The history of GLP-1 drugs illustrates how a naturally occurring gut peptide became one of the most commercially successful drug classes in pharmaceutical history.
Neuropeptides
These peptides act in the nervous system as neurotransmitters or neuromodulators. Endorphins (your body's natural painkillers) are peptides. Substance P (11 amino acids) transmits pain signals. Neuropeptide Y modulates stress, appetite, and anxiety. Vasoactive intestinal peptide (VIP, 28 amino acids) relaxes smooth muscle and suppresses inflammation.
Delgado et al. (2013) catalogued VIP's "pleiotropic" immune functions, meaning a single peptide acts on multiple cell types through multiple pathways.[6] This multi-functionality is a hallmark of neuropeptides and one reason they are difficult to develop as drugs: targeting one function often activates others.
Antimicrobial Peptides
Your innate immune system produces peptides that kill bacteria, viruses, and fungi directly. Defensins and cathelicidins are the two major families in humans. They work by binding to and disrupting microbial cell membranes, a mechanism that bacteria find difficult to develop resistance against because it targets a fundamental structural component rather than a specific metabolic pathway.
Li et al. (2023) reviewed how antimicrobial peptides are being developed as therapeutics for lung infections, fibrosis, and cancer, leveraging their natural membrane-disrupting properties.[4] Thapa et al. (2020) showed that topical antimicrobial peptide formulations can accelerate wound healing, though formulation challenges (protecting the peptide from degradation on skin surfaces) remain a barrier to commercial products.[7]
Structural and Signaling Peptides
Collagen, the most abundant protein in your body, is broken down into collagen peptides that signal fibroblasts to produce new collagen. Growth factors like EGF (epidermal growth factor) and PDGF (platelet-derived growth factor) are peptides that regulate cell growth, wound healing, and tissue repair. Natriuretic peptides (ANP, BNP) are released by the heart when it is under strain, signaling the kidneys to excrete sodium and water to reduce blood pressure.
How Peptide Drugs Work
The transition from natural peptides to pharmaceutical drugs requires solving three problems: getting the peptide to its target, keeping it intact long enough to work, and ensuring it binds its receptor with sufficient affinity.
The Delivery Problem
Most peptides cannot survive oral administration. Stomach acid (pH 1-2) denatures their structure, and digestive enzymes (pepsin, trypsin, chymotrypsin) cleave the peptide bonds holding them together. This is why insulin, discovered in 1921, is still injected more than a century later. Kim et al. (2024) reviewed how nanostructured delivery systems, including peptide-based nanoparticles, are being developed to protect therapeutic peptides during oral transit.[5]
Oral semaglutide (Rybelsus) solved this problem for one specific peptide by co-formulating it with SNAC, a fatty acid derivative that creates a local pH increase in the stomach and protects the peptide from enzymatic degradation. This represents a significant pharmaceutical achievement, but the technology is specific to semaglutide's properties and has not been generalized to other peptides.
The Stability Problem
Even after injection, peptides face rapid degradation. Blood proteases, kidney filtration, and liver metabolism clear most unmodified peptides within minutes. Drug developers use several strategies to extend peptide half-life:
Amino acid modifications. Replacing natural L-amino acids with D-amino acids (their mirror images) makes peptides invisible to proteases that evolved to recognize natural peptide bonds.
Lipidation. Attaching a fatty acid chain (as in semaglutide's C18 fatty acid) allows the peptide to bind albumin in the bloodstream, shielding it from degradation and slowing renal clearance. This extends semaglutide's half-life from minutes to approximately one week.
Cyclization. Connecting the ends of a peptide into a ring creates a cyclic peptide that resists unfolding and enzymatic attack. Many natural peptides (cyclosporine, vancomycin) are already cyclic.
PEGylation. Attaching polyethylene glycol chains increases the peptide's size, reducing kidney filtration and extending circulation time.
The Receptor Problem
Peptide drugs work by binding to the same receptors as their natural counterparts, but with optimized affinity or selectivity. Rosson et al. (2025) noted that peptides occupy a "unique niche" between small molecules and large biologics: they are more selective than small molecules (fewer off-target effects) but easier to manufacture than antibodies.[1] This middle position makes them attractive for targets that small molecules cannot reach and antibodies are too expensive or too large to access.
The Peptide Drug Landscape
More than 80 peptide drugs have been approved by the FDA, and over 150 are in active clinical trials.[1] The market exceeds $50 billion annually and is growing faster than the overall pharmaceutical market. Major categories include:
Metabolic disease. GLP-1 receptor agonists (semaglutide, tirzepatide, liraglutide) for diabetes and obesity. These are the highest-revenue peptide drugs ever developed, with semaglutide alone generating over $20 billion in annual sales.
Oncology. Peptide-drug conjugates deliver cytotoxic payloads to tumors. Somatostatin analogs (octreotide, lanreotide) treat neuroendocrine tumors. Peptide vaccines stimulate immune responses against cancer-specific antigens.
Immunology. Thymosin alpha-1 modulates immune function in hepatitis and sepsis. Ganea et al. (2015) described how neuropeptides like VIP can regulate entire immune cascades, pointing toward peptide-based approaches to autoimmune disease.[8]
Endocrinology. Insulin and its analogs for diabetes. Growth hormone-releasing peptides for growth hormone deficiency. GnRH analogs for prostate cancer and endometriosis.
Diagnostics. Peptide-based imaging agents (gallium-68-DOTATATE for neuroendocrine tumor PET scans) and biomarkers (BNP for heart failure, procalcitonin for sepsis).
Hashemi et al. (2024) reviewed how artificial intelligence is accelerating peptide drug discovery, with machine learning models now capable of predicting peptide-receptor binding, protease stability, and membrane permeability from sequence data alone.[2] Zhang et al. (2024) focused on how therapeutic peptides are being designed to modulate the cancer-immunity cycle, combining the selectivity of peptide targeting with the potency of immune activation.[9]
Peptides You Already Encounter
Peptides are not just pharmaceutical compounds. They are present in food, skincare, and your body's daily operations:
In food. Collagen peptides (from bone broth, supplements, or hydrolyzed collagen products) are fragments of the collagen protein. Casein-derived peptides in dairy have been studied for blood pressure effects. Glutathione, a tripeptide (three amino acids), is a major antioxidant produced in every cell.
In skincare. Matrixyl (palmitoyl pentapeptide-4), Argireline (acetyl hexapeptide-8), and GHK-Cu (copper peptide) are marketed as anti-aging ingredients. Their effectiveness depends on whether they can penetrate the skin barrier, a significant challenge for molecules of their size.
In your body right now. As you read this, peptide hormones are regulating your blood sugar, peptide neurotransmitters are processing this information in your brain, antimicrobial peptides are patrolling your skin and mucosal surfaces, and natriuretic peptides are balancing your blood pressure.
Dominari et al. (2020) described thymosin alpha-1 as an example of a naturally occurring thymic peptide that has been developed into a drug used in over 35 countries, illustrating how the body's own peptide repertoire serves as a starting library for pharmaceutical development.[10]
The Bottom Line
Peptides are short chains of amino acids (2-50 units) that function as hormones, neurotransmitters, immune defenders, and signaling molecules throughout the body. More than 80 peptide drugs have FDA approval, with the GLP-1 agonists for obesity and diabetes representing the highest-revenue class. The main challenge in peptide drug development remains delivery: most peptides are destroyed by stomach acid and blood proteases, requiring injection or specialized formulations. AI-driven design, chemical modifications, and advanced delivery systems are expanding what peptide drugs can do, making this the fastest-growing segment of the pharmaceutical market.